Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Hanan

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|May 1, 2020
Monomeric Targeted Protein DegradersEmily J Hanan, Jun Liang, Xiaojing Wang, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|August 6, 2008
Structure of the Brachydanio rerio Polo-like kinase 1 (Plk1) catalytic domain in complex with an extended inhibitor targeting the adaptive pocket of the enzymeRobert A Elling, Raymond V Fucini, Emily J Hanan, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitorsEmily J Hanan, Raymond V Fucini, Michael J Romanowski, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2015
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinaseEmily J Hanan, Matt Baumgardner, Marian C Bryan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry EyeMin Zhong, Thomas R Gadek, Minna Bui, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2010
Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonistsMin Zhong, Emily J Hanan, Wang Shen, et al.
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitorsRaymond V Fucini, Emily J Hanan, Michael J Romanowski, et al.
Mbio|September 9, 2020
Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal PeptidaseHomer Pantua, Elizabeth Skippington, Marie-Gabrielle Braun, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|May 1, 2020
Monomeric Targeted Protein DegradersEmily J Hanan, Jun Liang, Xiaojing Wang, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|August 6, 2008
Structure of the Brachydanio rerio Polo-like kinase 1 (Plk1) catalytic domain in complex with an extended inhibitor targeting the adaptive pocket of the enzymeRobert A Elling, Raymond V Fucini, Emily J Hanan, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitorsEmily J Hanan, Raymond V Fucini, Michael J Romanowski, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2015
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinaseEmily J Hanan, Matt Baumgardner, Marian C Bryan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry EyeMin Zhong, Thomas R Gadek, Minna Bui, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2010
Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonistsMin Zhong, Emily J Hanan, Wang Shen, et al.
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitorsRaymond V Fucini, Emily J Hanan, Michael J Romanowski, et al.
Mbio|September 9, 2020
Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal PeptidaseHomer Pantua, Elizabeth Skippington, Marie-Gabrielle Braun, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
Pageof 3